Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
$1.5B | $0.93 | 39.36% | 23.56% | $92.71 |
|
AJG
Arthur J. Gallagher & Co.
|
$3.5B | $2.54 | 33.01% | 115.27% | $301.28 |
|
CRVL
CorVel Corp.
|
-- | -- | -- | -- | -- |
|
EHTH
eHealth, Inc.
|
$52.1M | -$1.43 | 0.97% | -4.03% | $8.50 |
|
KINS
Kingstone Cos., Inc.
|
$47.2M | $0.71 | 37.6% | 33.96% | $22.00 |
|
MMC
Marsh & McLennan Cos., Inc.
|
$6.3B | $1.78 | 8.46% | 24.19% | $211.33 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
$80.90 | $92.71 | $27.6B | 24.28x | $0.17 | 0.76% | 4.41x |
|
AJG
Arthur J. Gallagher & Co.
|
$260.64 | $301.28 | $66.9B | 41.47x | $0.65 | 1% | 5.06x |
|
CRVL
CorVel Corp.
|
$68.88 | -- | $3.5B | 33.94x | $0.00 | 0% | 3.83x |
|
EHTH
eHealth, Inc.
|
$4.15 | $8.50 | $127.7M | 111.86x | $0.00 | 0% | 0.23x |
|
KINS
Kingstone Cos., Inc.
|
$17.38 | $22.00 | $245.9M | 7.89x | $0.05 | 0.58% | 1.35x |
|
MMC
Marsh & McLennan Cos., Inc.
|
$185.90 | $211.33 | $91.1B | 22.30x | $0.90 | 1.85% | 3.48x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
39.34% | -0.339 | 25.4% | 0.17x |
|
AJG
Arthur J. Gallagher & Co.
|
37.1% | 0.003 | 17.2% | 0.03x |
|
CRVL
CorVel Corp.
|
6.66% | -0.183 | 0.65% | 1.38x |
|
EHTH
eHealth, Inc.
|
9.49% | -0.435 | 18.45% | 1.47x |
|
KINS
Kingstone Cos., Inc.
|
4.36% | 0.032 | 2.36% | 0.00x |
|
MMC
Marsh & McLennan Cos., Inc.
|
58.58% | -0.205 | 22.1% | 0.12x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
$1.5B | $422M | 6.97% | 11.39% | 26.28% | $452M |
|
AJG
Arthur J. Gallagher & Co.
|
$3B | $536.6M | 4.91% | 7.95% | 15.94% | $693.5M |
|
CRVL
CorVel Corp.
|
$50.3M | $35.9M | 30.03% | 32.69% | 14.98% | $15.3M |
|
EHTH
eHealth, Inc.
|
-- | -$41.1M | 5.08% | 5.62% | -76.24% | -$29.9M |
|
KINS
Kingstone Cos., Inc.
|
-- | $13.8M | 34.54% | 38.25% | 27.01% | $25.3M |
|
MMC
Marsh & McLennan Cos., Inc.
|
-- | $1.4B | 12% | 28.77% | 21.66% | $2B |
Arthur J. Gallagher & Co. has a net margin of 14.14% compared to Brown & Brown, Inc.'s net margin of 8.13%. Brown & Brown, Inc.'s return on equity of 11.39% beat Arthur J. Gallagher & Co.'s return on equity of 7.95%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
93.34% | $0.68 | $20.4B |
|
AJG
Arthur J. Gallagher & Co.
|
90.6% | $1.05 | $36.9B |
Brown & Brown, Inc. has a consensus price target of $92.71, signalling upside risk potential of 15.95%. On the other hand Arthur J. Gallagher & Co. has an analysts' consensus of $301.28 which suggests that it could grow by 14.49%. Given that Brown & Brown, Inc. has higher upside potential than Arthur J. Gallagher & Co., analysts believe Brown & Brown, Inc. is more attractive than Arthur J. Gallagher & Co..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
2 | 13 | 0 |
|
AJG
Arthur J. Gallagher & Co.
|
10 | 7 | 0 |
Brown & Brown, Inc. has a beta of 0.816, which suggesting that the stock is 18.449% less volatile than S&P 500. In comparison Arthur J. Gallagher & Co. has a beta of 0.688, suggesting its less volatile than the S&P 500 by 31.226%.
Brown & Brown, Inc. has a quarterly dividend of $0.17 per share corresponding to a yield of 0.76%. Arthur J. Gallagher & Co. offers a yield of 1% to investors and pays a quarterly dividend of $0.65 per share. Brown & Brown, Inc. pays 15.63% of its earnings as a dividend. Arthur J. Gallagher & Co. pays out 36.92% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
Brown & Brown, Inc. quarterly revenues are $1.6B, which are smaller than Arthur J. Gallagher & Co. quarterly revenues of $3.4B. Brown & Brown, Inc.'s net income of $227M is lower than Arthur J. Gallagher & Co.'s net income of $273.6M. Notably, Brown & Brown, Inc.'s price-to-earnings ratio is 24.28x while Arthur J. Gallagher & Co.'s PE ratio is 41.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown, Inc. is 4.41x versus 5.06x for Arthur J. Gallagher & Co.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
4.41x | 24.28x | $1.6B | $227M |
|
AJG
Arthur J. Gallagher & Co.
|
5.06x | 41.47x | $3.4B | $273.6M |
CorVel Corp. has a net margin of 14.14% compared to Brown & Brown, Inc.'s net margin of 11.65%. Brown & Brown, Inc.'s return on equity of 11.39% beat CorVel Corp.'s return on equity of 32.69%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
93.34% | $0.68 | $20.4B |
|
CRVL
CorVel Corp.
|
21% | $0.54 | $388.7M |
Brown & Brown, Inc. has a consensus price target of $92.71, signalling upside risk potential of 15.95%. On the other hand CorVel Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Brown & Brown, Inc. has higher upside potential than CorVel Corp., analysts believe Brown & Brown, Inc. is more attractive than CorVel Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
2 | 13 | 0 |
|
CRVL
CorVel Corp.
|
0 | 0 | 0 |
Brown & Brown, Inc. has a beta of 0.816, which suggesting that the stock is 18.449% less volatile than S&P 500. In comparison CorVel Corp. has a beta of 1.091, suggesting its more volatile than the S&P 500 by 9.093%.
Brown & Brown, Inc. has a quarterly dividend of $0.17 per share corresponding to a yield of 0.76%. CorVel Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown, Inc. pays 15.63% of its earnings as a dividend. CorVel Corp. pays out -- of its earnings as a dividend. Brown & Brown, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Brown & Brown, Inc. quarterly revenues are $1.6B, which are larger than CorVel Corp. quarterly revenues of $239.6M. Brown & Brown, Inc.'s net income of $227M is higher than CorVel Corp.'s net income of $27.9M. Notably, Brown & Brown, Inc.'s price-to-earnings ratio is 24.28x while CorVel Corp.'s PE ratio is 33.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown, Inc. is 4.41x versus 3.83x for CorVel Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
4.41x | 24.28x | $1.6B | $227M |
|
CRVL
CorVel Corp.
|
3.83x | 33.94x | $239.6M | $27.9M |
eHealth, Inc. has a net margin of 14.14% compared to Brown & Brown, Inc.'s net margin of -58.83%. Brown & Brown, Inc.'s return on equity of 11.39% beat eHealth, Inc.'s return on equity of 5.62%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
93.34% | $0.68 | $20.4B |
|
EHTH
eHealth, Inc.
|
-- | -$1.46 | $977.2M |
Brown & Brown, Inc. has a consensus price target of $92.71, signalling upside risk potential of 15.95%. On the other hand eHealth, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 104.82%. Given that eHealth, Inc. has higher upside potential than Brown & Brown, Inc., analysts believe eHealth, Inc. is more attractive than Brown & Brown, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
2 | 13 | 0 |
|
EHTH
eHealth, Inc.
|
1 | 4 | 0 |
Brown & Brown, Inc. has a beta of 0.816, which suggesting that the stock is 18.449% less volatile than S&P 500. In comparison eHealth, Inc. has a beta of 1.271, suggesting its more volatile than the S&P 500 by 27.113%.
Brown & Brown, Inc. has a quarterly dividend of $0.17 per share corresponding to a yield of 0.76%. eHealth, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown, Inc. pays 15.63% of its earnings as a dividend. eHealth, Inc. pays out -55.3% of its earnings as a dividend. Brown & Brown, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Brown & Brown, Inc. quarterly revenues are $1.6B, which are larger than eHealth, Inc. quarterly revenues of $53.9M. Brown & Brown, Inc.'s net income of $227M is higher than eHealth, Inc.'s net income of -$31.7M. Notably, Brown & Brown, Inc.'s price-to-earnings ratio is 24.28x while eHealth, Inc.'s PE ratio is 111.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown, Inc. is 4.41x versus 0.23x for eHealth, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
4.41x | 24.28x | $1.6B | $227M |
|
EHTH
eHealth, Inc.
|
0.23x | 111.86x | $53.9M | -$31.7M |
Kingstone Cos., Inc. has a net margin of 14.14% compared to Brown & Brown, Inc.'s net margin of 21.42%. Brown & Brown, Inc.'s return on equity of 11.39% beat Kingstone Cos., Inc.'s return on equity of 38.25%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
93.34% | $0.68 | $20.4B |
|
KINS
Kingstone Cos., Inc.
|
-- | $0.74 | $112.6M |
Brown & Brown, Inc. has a consensus price target of $92.71, signalling upside risk potential of 15.95%. On the other hand Kingstone Cos., Inc. has an analysts' consensus of $22.00 which suggests that it could grow by 26.58%. Given that Kingstone Cos., Inc. has higher upside potential than Brown & Brown, Inc., analysts believe Kingstone Cos., Inc. is more attractive than Brown & Brown, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
2 | 13 | 0 |
|
KINS
Kingstone Cos., Inc.
|
1 | 0 | 0 |
Brown & Brown, Inc. has a beta of 0.816, which suggesting that the stock is 18.449% less volatile than S&P 500. In comparison Kingstone Cos., Inc. has a beta of 0.420, suggesting its less volatile than the S&P 500 by 58.043%.
Brown & Brown, Inc. has a quarterly dividend of $0.17 per share corresponding to a yield of 0.76%. Kingstone Cos., Inc. offers a yield of 0.58% to investors and pays a quarterly dividend of $0.05 per share. Brown & Brown, Inc. pays 15.63% of its earnings as a dividend. Kingstone Cos., Inc. pays out -- of its earnings as a dividend. Brown & Brown, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Brown & Brown, Inc. quarterly revenues are $1.6B, which are larger than Kingstone Cos., Inc. quarterly revenues of $50.8M. Brown & Brown, Inc.'s net income of $227M is higher than Kingstone Cos., Inc.'s net income of $10.9M. Notably, Brown & Brown, Inc.'s price-to-earnings ratio is 24.28x while Kingstone Cos., Inc.'s PE ratio is 7.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown, Inc. is 4.41x versus 1.35x for Kingstone Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
4.41x | 24.28x | $1.6B | $227M |
|
KINS
Kingstone Cos., Inc.
|
1.35x | 7.89x | $50.8M | $10.9M |
Marsh & McLennan Cos., Inc. has a net margin of 14.14% compared to Brown & Brown, Inc.'s net margin of 11.89%. Brown & Brown, Inc.'s return on equity of 11.39% beat Marsh & McLennan Cos., Inc.'s return on equity of 28.77%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
93.34% | $0.68 | $20.4B |
|
MMC
Marsh & McLennan Cos., Inc.
|
-- | $1.51 | $36.8B |
Brown & Brown, Inc. has a consensus price target of $92.71, signalling upside risk potential of 15.95%. On the other hand Marsh & McLennan Cos., Inc. has an analysts' consensus of $211.33 which suggests that it could grow by 13.68%. Given that Brown & Brown, Inc. has higher upside potential than Marsh & McLennan Cos., Inc., analysts believe Brown & Brown, Inc. is more attractive than Marsh & McLennan Cos., Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
2 | 13 | 0 |
|
MMC
Marsh & McLennan Cos., Inc.
|
5 | 14 | 0 |
Brown & Brown, Inc. has a beta of 0.816, which suggesting that the stock is 18.449% less volatile than S&P 500. In comparison Marsh & McLennan Cos., Inc. has a beta of 0.755, suggesting its less volatile than the S&P 500 by 24.514%.
Brown & Brown, Inc. has a quarterly dividend of $0.17 per share corresponding to a yield of 0.76%. Marsh & McLennan Cos., Inc. offers a yield of 1.85% to investors and pays a quarterly dividend of $0.90 per share. Brown & Brown, Inc. pays 15.63% of its earnings as a dividend. Marsh & McLennan Cos., Inc. pays out 38.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
Brown & Brown, Inc. quarterly revenues are $1.6B, which are smaller than Marsh & McLennan Cos., Inc. quarterly revenues of $6.4B. Brown & Brown, Inc.'s net income of $227M is lower than Marsh & McLennan Cos., Inc.'s net income of $757M. Notably, Brown & Brown, Inc.'s price-to-earnings ratio is 24.28x while Marsh & McLennan Cos., Inc.'s PE ratio is 22.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown, Inc. is 4.41x versus 3.48x for Marsh & McLennan Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
BRO
Brown & Brown, Inc.
|
4.41x | 24.28x | $1.6B | $227M |
|
MMC
Marsh & McLennan Cos., Inc.
|
3.48x | 22.30x | $6.4B | $757M |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.